Biography

1.Research Interest : Basic and clinical research on transformation of liver inflammation to hepatocellular carcinoma

2.Educational Background :

2007.9-2011.6: Tianjin Medical University, Medical PhD

2001.9-2004.6: Tianjin Medical University, Master's degree of

Medicine.

1987.9-1992.6: Shandong University, Bachelor's degree of

Medicine.

2012.8-2012.9:Taiwan Fu Jen Catholic University, Advanced Study

2016.8-2016.9: Johns Hopkins Hospital of USA, Advanced Study

3. Work Experience :

2015.8-Present: Vice president of Tianjin Third Central Hospital

2013.9-Present: Director of the Departmentof Gastroenterology and Hepatology ,Tianjin Third Central Hospital

2012.10-Presented:Chief Physician, Department of Gastroenterology and Hepatology ,Tianjin Third Central Hospital

2004.1-2012.10:Associate Chief Physician, Department of Hepatology, Tianjin Third Central Hospital.

1992.07-2003.12:Attending Physician, Department of

Gastroenterology, Emergency Department, Tianjin Third Central Hospital

4.Awards:

1)Outstanding teacher of Tianjin Medical University in 2008

2)Outstanding pacesetter against SARS in 2003

3)’May 1’ Labour Award of Tianjin in 2015

4) Woman Pace-setter of Tianjin in 2017

5) 131 engineering innovation talent of Tianjin

5. Social Service:

1)Young Committee Member of Chinese society of Hepatology , Chinese Medical Association

2) Member of the Hepatobiliary Group of the Chinese society of Gastroenterology ,Chinese Medical Association

3) Member of Digestive Branch of Chinese Medical Doctor Association

4)Vice Chairman of Digestive Diseases Branch of Tianjin Medical Association

Achievements :

Peer-Reviewed Journal Papers :

1 Wang F, Lv H, Wang F. Complete cure of a patient with HBV-associated hepatocellular carcinoma with lung metastasis using interferon and survival up to 108 months: A case report and literature review. Oncol Lett. 2018;16(3):2979-2988 (Corresponding Author)

2 Wang F, Cui S, Wang F, Li F, Tang F, Zhang X, Gao Y, Lv H. Different scoring systems to predict 6-week mortality in cirrhosis patients with acute variceal bleeding: a retrospective analysis of 202 patients. Scand J Gastroenterol. 2018;53(7):885-890.

3 Zhou Y, Xu X, Ding J, Jing X, Wang F, Wang Y, Wang P. Dynamic changes of T-cell subsets and their relation with tumor recurrence after microwave ablation in patients with hepatocellular carcinoma. J Cancer Res Ther. 2018;14(1):40-45

4 Ding J, Zhou Y, Wang Y, Jing X, Wang F, Wang Y. Percutaneous microwave ablation of exophytic tumours in hepatocellular carcinoma patients: Safe or not? Liver Int. 2017;37(9):1365-1372

5 Liang J, Liu F, Wang F, et al. A Noninvasive Score Model for Prediction of NASH in Patients with Chronic Hepatitis B and Nonalcoholic Fatty Liver Disease. Biomed Res Int. 2017;2017:8793278.(Corresponding Author)

6Yin W, Ye Q, Wang Fet al. ART score and hepatocellular carcinoma: An appraisal of its applicability. Clin Res Hepatol Gastroenterol. 2016;40(6):705-714.

7 Xu Z, Wang F, Fan F et al. Quantitative Proteomics Reveals That theInhibition of Na(+)/K(+)-ATPase Activity Affects S-Phase Progression Leading to a Chromosome Segregation Disorder by Attenuating the Aurora A Function in Hepatocellular Carcinoma Cells. J Proteome Res. 2015 Nov 6;14(11):4594-602.(Corresponding Author)

8 Liu H, Li J, Wang F, Gao Y, Luo Y, Wang P, Li C, Zhu Z. Comparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinoma. Tumour Biol. 2015 Apr;36(4):2299-307.(Corresponding Author)

9 Huang Y, Wang F, Wang Y, Intrahepatic IL-17(+) T cells and FoxP3(+) Tregs cooperate to promote development and affect the prognosis of hepatocellular carcinoma.J Gastroenterol Hepatol. 2014;29(4):851-9. (Corresponding Author)

10. Huang Y,Wang F,Wang Y et al.Prognostic Value of Tumor-infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis, plOs one. 2014 14;9(5):e94376. (Corresponding Author)

11.Wang F, Jing X, Li Ge, et al. Foxp3+ Regulatory T cells are Associated with the Natural History of Chronic Hepatitis B and Poor Prognosis of Hepatocellular Carcinoma. Liver Int. 2012;32(4):644-55

12. Wang F, Jing X, Wang Tao ,et al. The differential diagnostic value of GPC3 combined CD34 staining in small liver nodules with diameter less than 3 cm. Am J Clin Pathol. 2012;137(6):937-45.

Researching Projects

1.Sub-topics on Prevention and control of major communicable diseases such as AIDS and viral hepatitis: Early diagnosis and early warning of liver cancer. National Science and Technology Major Projects 2017. Person in charge, No 2018ZX10732202, 2018.1- 2020.12

2.“Prediction system for early diagnosis of HBV related hepatocellular carcinoma”.Major Project of Tianjin Chronic Disease Prevention and Control. Person in charge, No 17ZXMFSY00170, 2017.10-2020.09

3.”HBV infection gene detection guided precise antiviral therapy of

hepatocellularcarcinoma”. Crucial Science and Technology Project of

Tianjin, Person in charge,No 16KG151, 2016-2019

4.” Study on the standardization and efficacy evaluation system of percutaneous thermal ablation for refractory hepatocellular carcinoma”. Major Project of Tianjin Chronic Disease Prevention and Control. Second in charge, No 17ZXMFSY00050, 2017.10-2020.09

Completed Project

1.“The role of Treg/Th17 in the development of HBV-infected liver

cancer”. Person in charge,No 2013JCYBJC22500

2.“The role of sodium and potassium ATPase in the regulation of tumor cell and vascular endothelial cell growth”, the Second Prize of Scientific Progress of the Chinese People's Armed Police Force (Certificate No. 2012-2-25-5)

3.”Early diagnosis of high-risk hepatitis B virus related hepatocellular carcinoma”.Scientific Research Project of Tianjin Health Bureau,No 05KYZ13.

4.Research on the effect of retinoic acid combined with fluorourea deoxynucleoside on liver cancer , the Second Prize of Science and Technology Progress of Tianjin Health Bureau

5.Research on heat-resistant liver regeneration stimulating factor, the Third Prize of Tianjin Science and Technology Progress.

6.Introduce new technology of  Treatment of liver cancer with CT guided lipiodol embolization with boiling salt water , Transcatheter hepatic artery portal vein intervention for liver cancer, filled the medical blank of Tianjin, and have achieved good Clinical Benefits.